Design, Synthesis and Anticancer Evaluation of Nitroimidazole Radiosensitisers
The role of hypoxic tumour cells in resistance to radiotherapy, and in suppression of immune response, continues to endorse tumour hypoxia as a bona fide, yet largely untapped, drug target.Radiotherapy innovations such as stereotactic redken color fusion 7cr body radiotherapy herald new opportunities for classical oxygen-mimetic radiosensitisers.On